137 related articles for article (PubMed ID: 1286991)
1. Artificial surfaces in apheresis devices: interactions with the complement system.
Malchesky PS
J Clin Apher; 1992; 7(3):145-6. PubMed ID: 1286991
[TBL] [Abstract][Full Text] [Related]
2. Complement activation by LDL-apheresis using dextran sulphate.
Pascual M; Blanc E; Schifferli JA
Nephrol Dial Transplant; 1995; 10(8):1475-6. PubMed ID: 8538956
[No Abstract] [Full Text] [Related]
3. Apheresis and biocompatibility: complement activation.
Belloni M; Alghisi A; Scremin L
Int J Artif Organs; 1993 Dec; 16 Suppl 5():217-9. PubMed ID: 8013993
[TBL] [Abstract][Full Text] [Related]
4. Present status of apheresis technologies: Part 1. Membrane plasma separator.
Sueoka A
Ther Apher; 1997 Feb; 1(1):42-8. PubMed ID: 10225780
[TBL] [Abstract][Full Text] [Related]
5. Membranes for therapeutic apheresis.
Nakaji S; Yamamoto T
Ther Apher; 2002 Aug; 6(4):267-70. PubMed ID: 12164795
[TBL] [Abstract][Full Text] [Related]
6. A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin.
Mollnes TE; Riesenfeld J; Garred P; Nordström E; Høgåsen K; Fosse E; Götze O; Harboe M
Artif Organs; 1995 Sep; 19(9):909-17. PubMed ID: 8687297
[TBL] [Abstract][Full Text] [Related]
7. Complement activation and cytokine production as consequences of immunological bioincompatibility of extracorporeal circuits.
Jahns G; Haeffner-Cavaillon N; Nydegger UE; Kazatchkine MD
Clin Mater; 1993; 14(4):303-36. PubMed ID: 10146611
[TBL] [Abstract][Full Text] [Related]
8. Applications of membrane technologies for therapeutic apheresis.
Sueoka A
Ther Apher; 1998 Nov; 2(4):252-6. PubMed ID: 10227750
[TBL] [Abstract][Full Text] [Related]
9. The effect of r-hirudin vs. heparin on blood-membrane interactions during hemodialysis.
van Wyk V; Badenhorst PN; Kotzé HF
Clin Nephrol; 1997 Dec; 48(6):381-7. PubMed ID: 9438098
[TBL] [Abstract][Full Text] [Related]
10. Membrane apheresis technology: historical perspective and new trends toward bioincompatible systems.
Nosé Y; Yamaji K; Sueoka A; Yamane S
Ther Apher; 1997 Feb; 1(1):5-12. PubMed ID: 10225773
[TBL] [Abstract][Full Text] [Related]
11. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
12. Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro.
Sperling C; Salchert K; Streller U; Werner C
Biomaterials; 2004 Sep; 25(21):5101-13. PubMed ID: 15109834
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility of dialysis membranes: effects of chronic complement activation.
Hakim RM; Fearon DT; Lazarus JM
Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
[TBL] [Abstract][Full Text] [Related]
14. Clinical sequelae of complement activation in hemodialysis.
Hakim RM
Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474
[TBL] [Abstract][Full Text] [Related]
15. Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition.
Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Mollnes TE
Ann Thorac Surg; 2004 Jul; 78(1):38-44; discussion 44-5. PubMed ID: 15223398
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
17. Super-Anticoagulant Heparin-Mimicking Hydrogel Thin Film Attached Substrate Surfaces to Improve Hemocompatibility.
He M; Cui X; Jiang H; Huang X; Zhao W; Zhao C
Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27676251
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the biocompatibility and long-term effect of LDL-apheresis by dextran sulfate-cellulose column.
Yamamoto A; Kojima S; Shiba-Harada M; Kawaguchi A; Hatanaka K
Artif Organs; 1992 Apr; 16(2):177-81. PubMed ID: 10078241
[No Abstract] [Full Text] [Related]
19. [Complement activation in heparin--plasma inhibitory effect of anticoagulants on serum complement activation, 2nd report].
Kobayashi E; Kitano E; Kondo H; Kitamura H
Rinsho Byori; 2000 Jan; 48(1):60-6. PubMed ID: 10756677
[TBL] [Abstract][Full Text] [Related]
20. Heparin-like polymer surfaces: control of coagulation and complement activation by insoluble functionalized polymers.
Labarre DJ
Int J Artif Organs; 1990 Oct; 13(10):651-7. PubMed ID: 2254040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
